What Is Radiotherapy? Techniques, Equipment and Safety

Radiotherapy uses high-energy ionizing radiation to damage cancer-cell DNA and stop or slow growth. A radiation oncologist directs the plan.

Yes. Both names describe the same broad treatment approach.

Radiotherapy is planned and delivered in licensed radiation-oncology facilities. You may request information through Anka Sağlık Hizmetleri; confirm the actual site, equipment and clinician first.

It may be used in breast, prostate, lung, head and neck, brain, cervical, rectal and other cancers depending on stage and treatment goals.

It may aim to cure selected localized cancers, alone or combined with other treatments; advanced disease may require disease control or symptom relief. There is no guaranteed outcome.

It may shrink a tumor before surgery, reduce recurrence risk afterward, offer definitive treatment or relieve pain, bleeding and pressure symptoms.

Approaches include external beam, internal brachytherapy and certain systemic radionuclide treatments. External techniques include IMRT, VMAT, IGRT and SRS/SBRT.

Intensity-modulated radiotherapy shapes the dose by varying beam intensity; it is not required in every case.

Volumetric modulated arc therapy adjusts the beam during gantry rotation to deliver a planned external radiation dose.

IGRT uses imaging before or during treatment to verify patient and target positioning.

SBRT precisely delivers larger doses over relatively few sessions to selected body tumors. Suitability depends on target size and nearby organs.

Despite its name, Gamma Knife is stereotactic radiosurgery for selected brain targets, not open surgery.

Brachytherapy places a radioactive source in or near the target, temporarily or permanently; it may be used for cervical, prostate and selected other cancers.

No. Proton beams may help in selected anatomies, but superiority and availability are not universal.

No. External beam therapy directs radiation from outside the body; systemic radionuclide therapy uses administered radioactive pharmaceuticals such as Lu-177.

No. Radiotherapy commonly targets a local region with beams, while chemotherapy medicines can act systemically. They may be combined.

After consultation and simulation, targets are outlined, dose is planned, and the patient is positioned while the machine delivers treatment.

A planning CT helps locate targets and organs at risk and calculate dose for many external-beam treatments.

A fitted thermoplastic mask may be used for head and neck or brain targets; it is not needed for every patient.

An appointment may take several minutes to tens of minutes including setup and imaging; SRS/SBRT may take longer.

Courses range from one session to several weeks; five sessions weekly is common, but hypofractionated and stereotactic schedules may be shorter.

The external radiation beam is generally not felt, although positioning or underlying disease may cause discomfort.

Fasting is not universal. Abdominal/pelvic preparation, sedation, brachytherapy or special imaging may require tailored instructions.

Some pelvic plans use bladder filling and bowel/rectal preparation. Follow the exact center-specific protocol.

The team reviews pathology, medical history and scans; CT, MRI, PET/CT, blood tests or other assessments may be requested.

No. External beam radiotherapy does not make you radioactive. Radiation precautions may differ after implants or radionuclide therapy.

Possible effects include tiredness, skin changes in the treated area, and site-specific swallowing, bowel, bladder or breathing symptoms.

Hair loss generally occurs in the treated field, not throughout the body. Persistence depends on dose and site.

Skin in the treatment field may change color, become dry or sore. Seek treatment-team advice on skin products.

Yes. Late effects may develop months or years later, such as fibrosis, organ changes or rarely a second cancer; risk depends on dose and field.

Diet advice depends on the treated region and swallowing or bowel issues; a dietitian may help if intake is inadequate.

Some people continue working, while fatigue and appointments may require schedule adjustments.

Gentle washing is often possible, but follow local instructions for sore skin, dressings or brachytherapy sites.

Not always. Some symptoms briefly worsen before improving over weeks; late effects need longer follow-up.

There is no same-day test result. Response is assessed over time with clinical review and appropriate imaging.

Follow-up timing depends on cancer type, other treatments and adverse effects; there is no single universal schedule.

Radiation effects evolve over time; imaging changes may take weeks or months to appear.

Yes. It may be sequenced or combined with surgery, chemotherapy, hormonal, immune or targeted therapies according to a multidisciplinary plan.

Choice depends on tumor type, stage, location, risks, health and preferences; the treatments are not always interchangeable.

Proton treatment and Gamma Knife are forms of radiation therapy for selected indications, not universal replacements.

Re-irradiation can be considered in selected cases, depending on prior dose, organ tolerances and disease status.

Radiotherapy is intended to control cancer, not spread it. Progression can occur due to tumor biology and requires clinical reassessment.

Costs depend on technique, fractions, planning, center and insurance. Request an itemized current estimate rather than relying on an unverified price.

Coverage depends on indication, contracts and policy; confirm preauthorization and any charges.

Patients traveling from Eskişehir, Kırıkkale, Çankırı, Konya, Kırşehir or Bolu should confirm the facility and plan repeated appointments, transport and lodging.

No. Indication, planning quality, QA, trained staff and follow-up matter. Illustrative brand images are not proof of equipment at a particular facility.

A radiation oncologist considers pathology, imaging, stage and multidisciplinary review.

Contact your treatment team promptly; do not change the schedule yourself. Management depends on the protocol.

Pregnancy or possible pregnancy must be disclosed. Experts assess fetal exposure and timing and consider alternatives where appropriate.

It can be used for selected childhood cancers with specialist planning because of growth and late-effect concerns.

Breath-hold or respiratory tracking may be used for selected left breast and thoracic/abdominal cases; not every patient needs it.

Seek urgent medical help for severe breathlessness, uncontrolled bleeding, chest pain, confusion or rapid deterioration.